Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP6 | P55212 | 3/20 | 0.53 |
| ▸ | GAA | P10253 | 3/20 | 0.53 |
| ▸ | NSD2 | O96028 | 2/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.53 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.52 |
| ▸ | NT5E | P21589 | 3/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | ING2 | Q9H160 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 2/20 | 0.43 |
| ▸ | CA1 | P00915 | 4/20 | 0.42 |
| ▸ | CA2 | P00918 | 4/20 | 0.42 |
| ▸ | CA9 | Q16790 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | CA12 | O43570 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3857115 | 0.87 | ING2 (0.52) | CASP6GAANSD2L3MBTL1PLCG1 | |
| SCHEMBL2811005 | 0.85 | GAA (0.50) | CASP6GAANSD2L3MBTL1PLCG1 | |
| SCHEMBL28022985 | 0.85 | ING2 (0.50) | CASP6GAANSD2L3MBTL1PLCG1 | |
| SCHEMBL4649751 | 0.84 | CASP6 (0.62) | CASP6GAANSD2L3MBTL1PLCG1 | |
| SCHEMBL9463563 | 0.83 | CA1 (0.63) | GAAL3MBTL1CYP2C9CYP2C19THRB | |
| SCHEMBL29918476 | 0.83 | NT5E (0.47) | CASP6GAANSD2L3MBTL1PLCG1 | |
| SCHEMBL9297596 | 0.82 | NT5E (0.46) | CASP6GAANSD2L3MBTL1PLCG1 | |
| SCHEMBL9070253 | 0.80 | ALDH1A1 (0.52) | CASP6GAANSD2L3MBTL1PLCG1 | |
| SCHEMBL2865112 | 0.80 | CA1 (0.64) | CASP6GAANSD2L3MBTL1PLCG1 | |
| SCHEMBL176914 | 0.80 | CASR (0.45) | CASP6GAANSD2L3MBTL1PLCG1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 154 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE49569-E1 | Alkylamine derivative | EA PHARMA CO., LTD. (JP) | 2023-07-04 | — | — | US | disclosed |
| EP-2546231-B1 | ALKYLAMINE DERIVATIVE | EA PHARMA CO LTD (JP) | 2018-11-07 | — | — | EP | disclosed |
| US-9561216-B2 | Alkylamine derivative | EA PHARMA CO., LTD. (JP) | 2017-02-07 | — | — | US | disclosed |
| US-20160101091-A1 | ALKYLAMINE DERIVATIVE | AJINOMOTO CO., INC. (JP) | 2016-04-14 | — | — | US | disclosed |
| US-9253997-B2 | Alkylamine derivative | AJINOMOTO CO., INC. (JP) | 2016-02-09 | — | — | US | disclosed |
| US-9150505-B2 | Prophylactic or therapeutic agent for diabetes or obesity | AJINOMOTO CO., INC. (JP) | 2015-10-06 | — | — | US | disclosed |
| US-20130237702-A1 | ALKYLAMINE DERIVATIVE | AJINOMOTO CO., INC. (JP) | 2013-09-12 | — | — | US | disclosed |
| US-20130072491-A1 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR DIABETES OR OBESITY | AJINOMOTO CO., INC. (JP) | 2013-03-21 | — | — | US | disclosed |
| EP-2546231-A1 | ALKYLAMINE DERIVATIVE | Ajinomoto Co., Inc. (JP) | 2013-01-16 | — | — | EP | disclosed |
| EP-2543660-A1 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR DIABETES OR OBESITY | Ajinomoto Co., Inc. (JP) | 2013-01-09 | — | — | EP | disclosed |
| US-4083839-A | Unsymmetrical mono sulfo containing 1:2 azo, azo chromium complex dyes | CIBA-GEIGY CORPORATION (US) | 1978-04-11 | — | — | US | disclosed |
| US-RE29585-E | DYEING WOOL | CIBA-GEIGY CORPORATION (US) | 1978-03-21 | — | — | US | disclosed |
| US-4067864-A | FOR CELLULOSE OR POLYAMIDES | CIBA-GEIGY AG (CH) | 1978-01-10 | — | — | US | disclosed |
| US-4052386-A | REACTIVE PHTHALOCYANINE DYESTUFFS CONTAINING A FLUOROPYRIMIDINYL GROUP | BAYER AKTIENGESELLSCHAFT (DT) | 1977-10-04 | — | — | US | disclosed |
| US-4039523-A | YELLOW | CIBA-GEIGY AG (CH) | 1977-08-02 | — | — | US | disclosed |
| US-4033942-A | Chromium complex dye, including azo and azo methine dye compounds | CIBA-GEIGY AG (CH) | 1977-07-05 | — | — | US | disclosed |
| US-4017477-A | 3-Halogeno-6-hydroxy-pyridone-(2) azo dyestuffs | CIBA-GEIGY AG (CH) | 1977-04-12 | — | — | US | disclosed |
| US-4007164-A | FIBER-REACTIVE, CELLULOSE, WOOL | BAYER AKTIENGESELLSCHAFT (DT) | 1977-02-08 | — | — | US | disclosed |
| US-3971738-A | Heavy metal complexes of azo compounds containing a halogeno-2,3-dihydroxy pyridine coupling component | CIBA-GEIGY AG (CH) | 1976-07-27 | — | — | US | disclosed |
| US-3933785-A | Azo compounds | CIBA-GEIGY AG (CH) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130072491-A1 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR DIABETES OR OBESITY | CASR, GPR119, GLP1R | CASP6 1826/4885GAA 475/4885NSD2 3648/4885 |
| US-20160101091-A1 | ALKYLAMINE DERIVATIVE | CASR, TAAR5, TAAR1 | CASP6 1829/4885GAA 3022/4885NSD2 1189/4885 |
| US-20130237702-A1 | ALKYLAMINE DERIVATIVE | CASR, TAAR5, TAAR1 | CASP6 1829/4885GAA 3022/4885NSD2 1189/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.